TREATMENT OF TINEA CAPITIS WITH A NEW ANTIFUNGAL COMPOUND

Publisher Website
Google Scholar
Abstract
DURING the past few years various antifungal agents were introduced for the treatment of tinea capitis, especially the anthropophilic1 type caused by Microsporum audouini. Conflicting results have been reported, with cure rates varying from 10 to 100 per cent.2 In general, the time required for cure has been six or more months of arduous, meticulous treatment. As a consequence, many physicians resorted to x-ray epilation, which unquestionably is the most rapid method of therapy today. However, the obvious advantages of topical treatment of tinea capitis have impelled the members of the medical profession to continue their search for an antifungal agent which is distinguished by low toxicity, a low sensitizing index, rapid effectiveness and ease of application and which would be cosmetically acceptable to the patient. The present report deals with results attending the use of a new antifungal compound which more nearly approximates having these properties than

This publication has 5 references indexed in Scilit: